3 February 2012 - Sequenom Inc (NASDAQ:SQNM), a US-based diagnostic testing and genetics analysis company, said on Thursday that an independent study on Sequenom Centre for Molecular Medicine's MaterniT21 laboratory-developed test (LDT) showed that the test can detect foetal trisomy 21, 18 and ...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up